Wipfli Financial Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Wipfli Financial Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$115K	Buy	+415	New	+$106K	0.01%	671

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wipfli Financial Advisors's SWAV Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2022: 415 shares worth $115K. The stake represents 0.01% of the portfolio and ranks #671 among its holdings.

412 funds tracked by Wall St. Rank hold SWAV as of Q3 2022.

Wipfli Financial Advisors held 415 shares of Shockwave Medical, Inc. Common Stock worth $115K as of Q3 2022.
Shockwave Medical, Inc. Common Stock was a new Wipfli Financial Advisors position in Q3 2022.
Shockwave Medical, Inc. Common Stock made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #671 holding.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.